This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

Troutman Pepper Locke

All Posts
| less than a minute read

FDA Announces a Single Pivotal Trial as the New Default Standard for All Drug Approvals and Unveils a Plausible Mechanism Framework for Individualized Therapies

Get in touch

Avatar
Kyle Dolinsky
Partner

Get in touch

Avatar
Kyle Dolinsky
Partner

FDA shifts to a single pivotal trial default and issues plausible mechanism guidance to speed individualized therapies for rare genetic diseases.

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration (FDA), a federal agency of the Department of Health and Human Services (HHS).

Get in touch

Avatar
Kyle Dolinsky
Partner

Get in touch

Avatar
Kyle Dolinsky
Partner

Latest Insights